Totally agree. And because of the rapid way this cancer progresses, any meaninful extension of life will be noted from early on. Great news for patients if this is to happen. And one of the triggers for early approval from the FDA. Relapsed patients have no other options.
Fingers crossed for those suffering from GBM and shareholders alike.
COH dealing with “from bench to bedside” as they say, is a huge bonus, as you have said.
Almost 50% of shares unable to be traded for the next 22 months, its hard to build a position without raising the share price.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)